Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Interest Coverage Ratio (2017 - 2019)

Historic Interest Coverage Ratio for Vistagen Therapeutics (VTGN) over the last 6 years, with Q4 2019 value amounting to 3975.33.

  • Vistagen Therapeutics' Interest Coverage Ratio rose 19948.97% to 3975.33 in Q4 2019 from the same period last year, while for Sep 2020 it was 10427.67, marking a year-over-year increase of 29104.63%. This contributed to the annual value of 3069.54 for FY2019, which is 9239.19% down from last year.
  • According to the latest figures from Q4 2019, Vistagen Therapeutics' Interest Coverage Ratio is 3975.33, which was up 19948.97% from 3995.72 recorded in Q4 2018.
  • In the past 5 years, Vistagen Therapeutics' Interest Coverage Ratio registered a high of 3975.33 during Q4 2019, and its lowest value of 4078.0 during Q1 2018.
  • In the last 3 years, Vistagen Therapeutics' Interest Coverage Ratio had a median value of 1884.83 in 2018 and averaged 1566.59.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 17942.48% in 2018, then skyrocketed by 19948.97% in 2019.
  • Quarter analysis of 3 years shows Vistagen Therapeutics' Interest Coverage Ratio stood at 1434.0 in 2017, then plummeted by 178.64% to 3995.72 in 2018, then soared by 199.49% to 3975.33 in 2019.
  • Its last three reported values are 3975.33 in Q4 2019, 3995.72 for Q4 2018, and 2477.33 during Q3 2018.